Menu Back to Pharmacovigilance-and-Risk-Management-Strategies-2015

Program Committee

  • William W. Gregory, PhD
    William W. Gregory, PhD Senior Director, Worldwide Safety and Regulatory Pfizer Inc, United States
  • Stella C.F. Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
    Stella C.F. Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP Vice President, Global Head of Risk Management Quintiles Inc., United Kingdom
  • Mariette  Boerstoel-Streefland, MD, MBA, MS
    Mariette Boerstoel-Streefland, MD, MBA, MS Head, Global Safety and Pharmacovigilance Baxter International Inc. , United States
  • Jean-Pierre  Clement, MD
    Jean-Pierre Clement, MD Vice President Global PV and Medical Risk Management Cubist Pharmaceuticals, Inc., United States
  • Stephen  Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP Senior Director, Global Patient Safety Eli Lilly and Company, United States
  • Michael  Richardson, MD, FFPM
    Michael Richardson, MD, FFPM International Head GPV&E and EU QPPV Bristol-Myers Squibb, United Kingdom
  • Tracy M Salaam, PharmD
    Tracy M Salaam, PharmD Safety Evaluator Team Leader, CDER FDA, United States
  • Stewart  Geary, MD
    Stewart Geary, MD Senior Vice President, Chief Medical Officer Eisai Co., Ltd., Japan
Load More